BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Akebia Therapeutics, Inc. 

9987 Carver Road
Suite 420
Cincinnati  Ohio  45242  U.S.A.
Phone: 513-618-0931 Fax: 513-618-0950


SEARCH JOBS










 Company News
Akebia Therapeutics, Inc. (AKBA) Appoints Michael Clayman, M.D. And Maxine Gowen, Ph.D. To Its Board Of Directors 7/17/2014 11:37:00 AM
Akebia Therapeutics, Inc. (AKBA) Added To Russell 3000®, Russell 2000® And Russell Global Indexes 6/30/2014 11:25:22 AM
Akebia Therapeutics, Inc. (AKBA), Trading M&A For An IPO—Becoming A Huge Contender In Anemia Drug Race 6/9/2014 6:54:03 AM
Akebia Therapeutics, Inc. (AKBA) To Present At The Annual UBS Global Healthcare Conference 5/12/2014 10:04:00 AM
Akebia Therapeutics, Inc. (AKBA) Announces Completion Of Enrollment In Its Phase 2b Clinical Study Of AKB-6548 4/15/2014 8:59:54 AM
Akebia Therapeutics, Inc. (AKBA) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 3/26/2014 9:38:25 AM
Cambridge's Akebia Therapeutics, Inc. (AKBA) Hauls In $100 Million In Upsized IPO Debut 3/20/2014 6:50:37 AM
Startup, Akebia Therapeutics, Inc., Files For $75 Million IPO 2/19/2014 7:44:59 AM
Akebia Therapeutics, Inc. Appoints Michael Wyzga To Its Board Of Directors 2/18/2014 8:26:58 AM
Akebia Therapeutics, Inc. Strengthens Its Leadership Team With Key Additions 1/13/2014 7:27:03 AM
1234